QLIF-03. UNUSUAL ADVERSE DRUG REACTIONS IN HIGH GRADE GLIOMA PATIENTS TREATED WITH TEMOZOLOMIDE

BACKGROUND: Temozolomide (TMZ) is an oral alkylating agent which is the most common chemotherapy used in neuro-oncology and is typically well tolerated. The most common adverse events include fatigue, nausea, vomiting, headache, and constipation and most serious being myelosuppression. Review of the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Lisa, Boris, Vera, Elizabeth, Wu, Jing, Park, Deric M, Bryla, Christine, Crandon, Sonja, Garren, Nancy, McCoy, Ann, Siegel, Christine, Theeler, Brett J, Sul, Joo-Hee, Gilbert, Mark, Armstrong, Terri
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692332/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.814
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados